XML 58 R46.htm IDEA: XBRL DOCUMENT v3.25.2

Restructuring Costs and Similar Items (Tables)

6 Months Ended

Jun. 30, 2025

Analysis of income and expense [abstract]

Summary of Restructuring Costs and Similar Items

Restructuring costs and similar items comprise the following:

(€ million)			June 30, 2025 (6 months)			June 30, 2024    (6 months) (a)
Employee-related expenses			201			810
Charges, gains or losses on assets(b)			109			(27)
Costs of transformation programs			80			114
Other restructuring costs			40			163
Total			430			1,060

(a) Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.

(b) This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.

X

- References

No definition available.

+ Details

Name:	ifrs-full_AnalysisOfIncomeAndExpenseAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of restructuring costs details.

+ References

No definition available.

+ Details

Name:	sny_DisclosureOfRestructuringCostsDetailsTableTextBlock
Namespace Prefix:	sny_
Data Type:	dtr-types1:textBlockItemType
Balance Type:	na
Period Type:	duration